NYXH Stock Analysis: Buy, Sell, or Hold?
NYXH - Nyxoah SA Ordinary Shares
$1.60
-0.04 (-2.44%)
âŧ
5d:
-1.23%
30d:
+8.84%
90d:
-44.25%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When NYXH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: NYXH is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: NYXH is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: NYXH is currently trading at $1.60, which is considered slightly high relative to its 30-day fair value range of $1.42 to $1.61.
Technical Outlook: Technically, NYXH is in a strong downtrend. Immediate support is located at $1.50, while resistance sits at $1.70.
Market Sentiment: NYXH scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.39 (+174.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NYXH is in a strong downtrend. Immediate support is located at $1.50, while resistance sits at $1.70.
Market Sentiment: NYXH scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.39 (+174.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.42 -
$1.61
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
42.1%
All Signals
- BEARISH: Weak technical setup (13/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 174.5% below Wall St target ($4.39)
- WARNING: Composite score 35/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.42 -
$1.61
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.50
Resistance Level
$1.70
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.91
Wall Street Target
$4.39
(+174.5%)
Revenue Growth (YoY)
472.8%
Share & Embed Analysis
Last updated: August 23, 2026 11:27 AM ET
Data refreshes hourly during market hours. Next update: 12:27 PM
Data refreshes hourly during market hours. Next update: 12:27 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NYXH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 46 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 37 SELL |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
13 analysts |
$405 | 66 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
